期刊文献+

还原型辅酶Ⅱ氧化酶/血管过氧化酶途径促大鼠心肌缺血再灌注氧化损伤 被引量:4

NADPH oxidase inhibitor apocynin attenuates ischemia/reperfusion induced myocardial injury inrats
原文传递
导出
摘要 目的研究还原型辅酶Ⅱ(NADPH)氧化酶/血管过氧化酶(NOX/VPO)途径在心肌缺血再灌注(L/R)氧化损伤中的作用和机制。方法雄性SD大鼠分为正常对照组,假手术组,缺血再灌注组(L/R组,大鼠心肌缺血1h,再灌注3h),夹竹桃麻素(apocynin)处理组(VR+apocynin组,再灌注开始前30min腹腔注射NOX特异性抑制剂apocynin)和溶媒对照组(L/R+vehicle组,再灌注开始前30min腹腔注射等体积apocynin溶媒)。每组动物数为7~8只。再灌注结束后测定心肌梗死面积、血清肌酸激酶(CK)活性、心肌组织细胞凋亡率和心肌组织细胞凋亡蛋白酶(easpase-3)含量及活性、NOX活性、NOX2和VP01mRNA和蛋白表达水平。结果L/R组VP01、NOX2mRNA和蛋白表达水平、NOX2酶活性水平、CK水平、心肌梗死面积、心肌细胞凋亡率均显著高于假手术组[两组上述指标分别为2.01±0.20比1.01±0.10,0.02±0.39比1.12±0.08,1.15±0.14比0.52±0.08,0.82±0.08比0.53±0.07,(14.1±1.2)比(9.1±1.2)仙mol·L-1·min-1·g-1,(2838.5±315.2)比(715.1±121.2)U/L,(52.1±2.1)%比(0.9±0.1)%和(23.5±3.5)%比(1.8±0.5)%,P均〈0.01]。L/R+apocynin组VP01、NOX2mRNA和蛋白表达水平、NOX2酶活性水平、CK水平、心肌梗死面积、心肌细胞凋亡率[分别为1.51±0.20,0.76±0.06,(12.1±1.0)斗m01.L-1·min-1·g-1,(1795.2±206.3)U/L,(21.5±2.2)%和(8.9±2.3)%]均显著低于I/R组(P均〈0.01)。VR+vehicle组上述指标与FR组比较差异均无统计学意义。结论NOX2/VP01途径在I/R氧化损伤中起重要作用,VP01与NOX2可能以H,0,为中介,共同促进了UR造成的氧化损伤。 Objective To explore the role of NADPH oxidase inhibitor apocynin on ischemia/ reperfusion (I/R)-induced myocardial injury. Methods Male SD rat hearts were divided into the normal control group; sham group; I/R group (1 h ischemia followed by 3 h reperfusion) ; I/R + apocynin group (50 mg/kg, administrated at 30 min before reperfusion) and I/R + vehicle group (same volume vehicle administrated at 30 min before reperfusion). At the end of reperfusion, myocardial infarct size, apoptosis, plasma CK activity, myocardial NOX activity, myocardial caspase-3 expression and activity, myocardial mRNA and protein expressions of vascular peroxidase 1 (VPO1) and NOX2 were measured. Results Infarct size, ratio of cardiomyocyte apoptosis, mRNA and protein expression of VOP1 and NOX2, serum CK, myocardial NOX and easpase-3 activities in the I/R group were all significantly increased compared to those in the sham group (P 〈0. 01 ). Above parameters were similar between//R + vehicle group and I/R group (all P 〉 0. 05 ). Infarct size, ratio of cardiomyocyte apoptosis, myocardial mRNA and protein expression of VOP1 and NOX2, serum CK, myocardial NOX and caspase-3 activities were significantly lower in I/R + apocynin group compared to those in I/R group ( all P 〈 0.01 ). Conclusions NOX/VPO pathway plays an important role in mediating I/R-induced myocardial oxidative injury. NOX inhibition could reduce I/R-induced myocardial oxidative iniurv by attenuating myocardial aoootosis in this model.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2012年第12期991-996,共6页 Chinese Journal of Cardiology
基金 国家自然科学基金资助项目(30971194) 全国优博专项基金(200787)
关键词 心肌再灌注损伤 NADPH氧化酶 过氧化物酶类 Myocardial reperfusion injury NADPH oxidase Peroxidases
  • 相关文献

参考文献16

  • 1Zhu XH, Yuan HJ, Wu YN, et al. Non-invasive limb ischemic pre-conditioning reduces oxidative stress and attenuates myocardium ischemia-reperfusion injury in diabetic rats. Free Radic Res, 2011,45: 201-210.
  • 2刘秀华,唐朝枢.缺血再灌注损伤的防治——从实验室到临床[J].中华心血管病杂志,2006,34(8):677-679. 被引量:33
  • 3Sirker A, Zhang M, Shah AM. NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies. Basic Res Cardiol, 2011,106: 735-747.
  • 4Cheng G, Salerno JC, Cao Z, et al. Identification and characterization of VPO1, a new animal heine-containing peroxidase. Free Radic Biol Med, 2008, 45: 1682-1694.
  • 5Shi R, Hu C, Yuan Q, et al. Involvement of vascular peroxidase 1 in angiotensin II -induced vascular smooth muscle cell proliferation. Cardiovasc Res, 2011,91: 27-36.
  • 6Silverio SC, Moreira S, Milagres AM, et al. Interference of some aqueous two-phase system phase-forming components in protein determination by the Bradford method. Anal Biochem, 2012, 421 : 719-724.
  • 7Peterson QP, Goode DR, West DC, et al. Preparation of the easpase-3/7 substrate Ae-DEVD-pNA by solution-phase peptide synthesis. Nat Protoe, 2010, 5 : 294-302.
  • 8Vashist SK, Zhang B, Zheng D, et al. Sulfo-N- hydroxysuccinimide interferes with bicinchoninic acid protein assay. Anal Biochem, 2011,417:156-158.
  • 9Csont T, Bereczki E, Bencsik P, et al. Hypercholesterolemia increases myocardial oxidative and nitrosative stress thereby leading to cardiac dysfunction in apoB-100 transgenic mice. Cardiovasc Res, 2007, 76:100-109.
  • 10Braunersreuther V, Jaquet V. Reactive oxygen species in myocardial reperfusion injury: from physiopathology to therapeutic approaches. Curr Pharm Biotechnol, 2012, 13 : 97-114.

二级参考文献15

  • 1Buja LM.Myocardial ischemia and reperfusion injury.Cardiovasc Pathol,2005,14:170-175.
  • 2Yellon DM,Hausenloy DJ.Realizing the clinical potential of ischemic preconditioning and postconditioning.Nat Clin Pract Cardiovasc Med,2005,2:568-575.
  • 3Okamoto F,Allen BS,Buckberg GD,et al.Reperfusion conditions:importance of ensuring gental versus sudden perfusion during relief of coronary occlusion.J Thorac Cardiovasc Surg,1986,92:613-620.
  • 4Hori M,Kitakaza M,Sato H,et al.Staged reperfusion attenuates myocardial stunning in dogs.Role of transient acidosis during early reperfusion.Circulation,1991,84:2135-2145.
  • 5Murry CE,Jennings RB,Reimer KA,et al.Preconditioning with ischemia:a delay of lethal cell injury in ischemic myocardium.Circulation,1986,74:1124-1136.
  • 6Liu XH,Wu XD,Cai LR,et al.Hypoxic preconditioning of cardiomyocytes and cardioprotection:Phophorylation of HIF-1 alpha induced by p42/p44 mitogen-activated protein kinases is involved.Pathophysiology,2003,9:201-205.
  • 7Liu XH,Wu XD,Han Y,et al.Signal pathway of cardioprotection induced by monophosphoryl lipid A in rabbit myocardium.Pathophysiology,2002,8:193-196.
  • 8Kloner RA,Rezkalla SH.Preconditioning,postconditioning and their application to clinical cardiology.Cardiovasc Res,2006,70:297-307.
  • 9Zhao ZQ,Corvera JS,Halkos ME,et al.Inhibition of myocardial injury by ischemic postconditioning during reperfusion:comparison with ischemic preconditioning.Am J Physiol Heart Circ Physiol,2003,285:H579-H588.
  • 10Vinten-Johansen J,Zhao ZQ,Zatta AJ,et al.Postconditioning-A new link in nature's armor against myocardial ischemia-reperfusion injury.Basic Res Cardiol,2005,100:295-310.

共引文献32

同被引文献29

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部